Compass Therapeutics annual total assets
2019
2019
2020
2020
2021
2022
2023
2024
2025
Compass Therapeutics Total Assets Growth & History (CMPX)
Compass Therapeutics's total assets was $219.6M for fiscal 2025.
View full Compass Therapeutics company overviewCompass Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $219.6M | $79.2M | +56.40% |
| 2024 | 2024-12-31 | $140.4M | −$16.5M | −10.50% |
| 2023 | 2023-12-31 | $156.9M | −$42.8M | −21.42% |
| 2022 | 2022-12-31 | $199.6M | $45.9M | +29.84% |
| 2021 | 2021-12-31 | $153.8M | $101.8M | +196.19% |
| 2020 · Dec 31 | 2020-12-31 | $51.9M | $51.9M | +4537574.83% |
| 2020 · Mar 31 | 2020-03-31 | $3,745 | −$1,121 | −23.04% |
| 2019 · Dec 31 | 2019-12-31 | $1,144 | — | — |
| 2019 · Mar 31 | 2019-03-31 | $4,866 | — | — |
Compass Therapeutics quarterly total assets
As of Mar 31, 2018
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q4.19
Q4.20
Q1.21
Q2.21
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $190.2M | $73.5M | +62.96% |
| Q1 2026 | 2026-03-31 | $205.2M | $73.7M | +56.08% |
| Q4 2025 | 2025-12-31 | $219.6M | $79.2M | +56.40% |
| Q3 2025 | 2025-09-30 | $231.3M | $82.1M | +55.05% |
| Q2 2025 | 2025-06-30 | $116.7M | −$38.9M | −25.01% |
| Q1 2025 | 2025-03-31 | $131.5M | −$29.7M | −18.43% |
| Q4 2024 | 2024-12-31 | $140.4M | −$16.5M | −10.50% |
| Q3 2024 | 2024-09-30 | $149.2M | −$20.9M | −12.28% |
| Q2 2024 | 2024-06-30 | $155.6M | −$23.6M | −13.15% |
| Q1 2024 | 2024-03-31 | $161.1M | −$26.8M | −14.27% |
| Q4 2023 | 2023-12-31 | $156.9M | −$42.8M | −21.42% |
| Q3 2023 | 2023-09-30 | $170.0M | $42.2M | +33.01% |
| Q2 2023 | 2023-06-30 | $179.2M | $38.9M | +27.75% |
| Q1 2023 | 2023-03-31 | $188.0M | $41.4M | +28.25% |
| Q4 2022 | 2022-12-31 | $199.6M | $45.9M | +29.84% |
| Q3 2022 | 2022-09-30 | $127.8M | $92.9M | +266.31% |
| Q2 2022 | 2022-06-30 | $140.3M | $99.4M | +243.16% |
| Q1 2022 | 2022-03-31 | $146.6M | $98.4M | +204.09% |
| Q4 2021 | 2021-12-31 | $153.8M | $101.8M | +196.19% |
| Q3 2021 | 2021-09-30 | $34.9M | −$25.8M | −42.50% |
| Q2 2021 · Jun 30 | 2021-06-30 | $40.9M | −$29.6M | −41.98% |
| Q1 2021 · Mar 31 | 2021-03-31 | $48.2M | $48.2M | +1286895.99% |
| Q4 2020 · Dec 31 | 2020-12-31 | $51.9M | $51.9M | +4537574.83% |
| Q2 2021 · Sep 30 | 2020-09-30 | $60.7M | $60.7M | +6880852.38% |
| Q1 2021 · Jun 30 | 2020-06-30 | $70.4M | $70.4M | +1447680.52% |
| Q4 2020 · Mar 31 | 2020-03-31 | $3,745 | −$1,121 | −23.04% |
| Q4 2019 · Dec 31 | 2019-12-31 | $1,144 | −$3,535 | −75.55% |
| Q2 2020 | 2019-09-30 | $882 | −$1,564 | −63.94% |
| Q1 2020 | 2019-06-30 | $4,866 | −$2,365 | −32.71% |
| Q4 2019 · Mar 31 | 2019-03-31 | $4,866 | $4,841 | +19364.00% |
| Q3 2019 | 2018-12-31 | $4,679 | — | — |
| Q2 2019 | 2018-09-30 | $2,446 | — | — |
| Q1 2019 | 2018-06-30 | $7,231 | — | — |
| As of Mar 31, 2018 | 2018-03-31 | $25 | — | — |
Compass Therapeutics total assets trends
Over the last five fiscal years, Compass Therapeutics's total assets increased from $51.9M to $219.6M, a change of $167.7M. The latest reported quarter, Q2 2026, shows $190.2M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Compass Therapeutics source filings ↗